DE60001182D1 - Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel - Google Patents

Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Info

Publication number
DE60001182D1
DE60001182D1 DE60001182T DE60001182T DE60001182D1 DE 60001182 D1 DE60001182 D1 DE 60001182D1 DE 60001182 T DE60001182 T DE 60001182T DE 60001182 T DE60001182 T DE 60001182T DE 60001182 D1 DE60001182 D1 DE 60001182D1
Authority
DE
Germany
Prior art keywords
erythromycin derivatives
medicines
manufacturing process
halo
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60001182T
Other languages
English (en)
Other versions
DE60001182T2 (de
Inventor
Alexis Denis
Claude Fromentin
Bertrand Heckmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE60001182D1 publication Critical patent/DE60001182D1/de
Application granted granted Critical
Publication of DE60001182T2 publication Critical patent/DE60001182T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60001182T 1999-02-04 2000-02-03 Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel Expired - Lifetime DE60001182T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901292A FR2789392B1 (fr) 1999-02-04 1999-02-04 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
DE60001182D1 true DE60001182D1 (de) 2003-02-20
DE60001182T2 DE60001182T2 (de) 2003-10-09

Family

ID=9541593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60001182T Expired - Lifetime DE60001182T2 (de) 1999-02-04 2000-02-03 Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel

Country Status (8)

Country Link
US (1) US6313101B1 (de)
EP (1) EP1026170B1 (de)
JP (2) JP5019665B2 (de)
AT (1) ATE231160T1 (de)
DE (1) DE60001182T2 (de)
DK (1) DK1026170T3 (de)
ES (1) ES2186615T3 (de)
FR (1) FR2789392B1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69933897T2 (de) * 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
WO2000044761A2 (en) 1999-01-27 2000-08-03 Pfizer Products Inc. Ketolide antibiotics
CZ20013733A3 (cs) 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
DE19948417A1 (de) * 1999-10-07 2001-04-19 Morphochem Ag Imidazol-Derivate und ihre Verwendung als Arzneimittel
ES2222966T3 (es) 2000-06-30 2005-02-16 Pfizer Products Inc. Macrolidos antibioticos.
US20080287376A1 (en) * 2004-07-28 2008-11-20 Mohammad Salman Ketolide Derivatives as Antibacterial Agents
WO2006046112A2 (en) * 2004-10-25 2006-05-04 Ranbaxy Laboratories Limited Ketolide derivatives as antibacterial agents
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
KR20130120458A (ko) * 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
AU2013239696C1 (en) 2012-03-27 2018-11-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
EP2968801B1 (de) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Verfahren zur behandlung von atemwegserkrankungen und formulierungen dafür
EP2968384A4 (de) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Konvergente verfahren zur herstellung antibakterieller makrolidmittel
CN104860943B (zh) * 2015-05-18 2017-11-17 上海毕路得医药科技有限公司 5,7‑二氯‑1h‑咪唑并[4,5‑b]吡啶的合成方法
CN106432383A (zh) * 2016-09-14 2017-02-22 重庆两江药物研发中心有限公司 索利霉素及其中间体的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2789392B1 (fr) 2001-10-05
JP2000229993A (ja) 2000-08-22
FR2789392A1 (fr) 2000-08-11
DK1026170T3 (da) 2003-05-05
EP1026170A1 (de) 2000-08-09
ATE231160T1 (de) 2003-02-15
JP2011136990A (ja) 2011-07-14
ES2186615T3 (es) 2003-05-16
JP5222348B2 (ja) 2013-06-26
EP1026170B1 (de) 2003-01-15
US6313101B1 (en) 2001-11-06
JP5019665B2 (ja) 2012-09-05
DE60001182T2 (de) 2003-10-09

Similar Documents

Publication Publication Date Title
DE60001182T2 (de) Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel
WO2002100860A3 (fr) Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
WO1999064409A3 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE50011034D1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69332259T2 (de) Kondensierte Thiadiazolderivate, Verfahren zu ihrer Herstellung und deren Verwendung
IL123776A0 (en) Novel derivatives of cyclodepsipeptide PF 1022
PT992509E (pt) Novos derivados macrolidos
BRPI0210746B8 (pt) derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação
DE69314911D1 (de) Cis-epoxide Derivate, verwendbar als irreversible HIV-Protease Inhibitoren und Verfahren und Zwischenprodukte zu ihrer Herstellung
DE3673468D1 (de) N-alkyl-2,6-dimethylmorpholinio-carbonsaeureamid-salze, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
WO2001090102A3 (de) 6-heterocyclyl-3-oxo-3,4-dihydro-chinoxaline
EP1319656A4 (de) Neues verfahren zur herstellung einer chinolon-carbonsäure
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
FR2787109B1 (fr) Nouveaux derives de 1,2-dithiolane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE171450T1 (de) Thiazolidin-2,4-dion-derivate, salze hiervon sowie verfahren zur herstellung
ATE279434T1 (de) Neue (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6h- pyridazino /1, 2-a/ /1, 2/ diazepin-1-carbonsäure-derivate, verfahren zu deren herstellung und deren verwendung zur herstellung pharmazeutischer wirkstoffe
ATE448198T1 (de) Neue alpha-ketoamidderivate und deren verwendung
DE69431498T2 (de) Loracarbef Hydrochlorid C1-C3 Alkohol-Solvate und deren Verwendungen
DE50000575D1 (de) Verfahren zur Herstellung von Folsäure
DE60313124D1 (de) Verfahren zur herstellung einer 1,2,3-triazolverbindung
WO2001010862A3 (de) Substituierte heterocyclylbenzofurane
DE60102113D1 (de) Ammonium-3,5,6-trihydroxyhexansäure-Derivate und Methoden zu ihrer Herstellung
ATE486843T1 (de) Ungeziefer abweisende mittel und verbindungen
IT1318465B1 (it) Processo per la preparazione di decaidro-2a, 4a,6a,8a-tetraazaciclopent(fg)acenaftilene e derivati funzionalizzati.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC